Literature DB >> 25143458

A current understanding of vascular calcification in CKD.

Neil J Paloian1, Cecilia M Giachelli2.   

Abstract

Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) have significant cardiovascular morbidity and mortality that is in part due to the development of vascular calcification. Vascular calcification is an active, highly regulated process that shares many similarities with normal bone formation. New discoveries related to extracellular vesicles, microRNAs, and calciprotein particles continue to reveal the mechanisms that are involved in the initiation and progression of vascular calcification in CKD. Further innovations in these fields are critical for the development of biomarkers and therapeutic options for patients with CKD and ESRD.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  calciprotein particles; chronic kidney disease; microRNA; vascular calcification; vesicles

Mesh:

Substances:

Year:  2014        PMID: 25143458      PMCID: PMC4200295          DOI: 10.1152/ajprenal.00163.2014

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  127 in total

Review 1.  Idiopathic infantile arterial calcification: two case reports, a review of the literature and a role for cardiac transplantation.

Authors:  Andrew C Glatz; Bruce R Pawel; Daphne T Hsu; Paul Weinberg; Maryanne R K Chrisant
Journal:  Pediatr Transplant       Date:  2006-03

Review 2.  Phosphate is a vascular toxin.

Authors:  Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2012-11-17       Impact factor: 3.714

3.  Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro.

Authors:  Hsueh Yang; Gabrielle Curinga; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

4.  Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.

Authors:  Guillaume Jean; Eric Bresson; Jean-Claude Terrat; Thierry Vanel; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Charles Chazot
Journal:  Nephrol Dial Transplant       Date:  2008-10-13       Impact factor: 5.992

5.  Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.

Authors:  Mhairi K Sigrist; Maarten W Taal; Peter Bungay; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-10       Impact factor: 8.237

6.  Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2.

Authors:  Matthew H Crouthamel; Wei Ling Lau; Elizabeth M Leaf; Nicholas W Chavkin; Mary C Wallingford; Danielle F Peterson; Xianwu Li; Yonggang Liu; Michael T Chin; Moshe Levi; Cecilia M Giachelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-22       Impact factor: 8.311

7.  Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles.

Authors:  Alexander Heiss; Thomas Eckert; Anke Aretz; Walter Richtering; Wim van Dorp; Cora Schäfer; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

8.  Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.

Authors:  Rukshana C Shroff; Rosamund McNair; Nichola Figg; Jeremy N Skepper; Leon Schurgers; Ashmeet Gupta; Melanie Hiorns; Ann E Donald; John Deanfield; Lesley Rees; Catherine M Shanahan
Journal:  Circulation       Date:  2008-10-06       Impact factor: 29.690

9.  ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release.

Authors:  Robert S Jansen; Aslı Küçükosmanoglu; Marcel de Haas; Sunny Sapthu; Jon Andoni Otero; Ilse E M Hegman; Arthur A B Bergen; Theo G M F Gorgels; P Borst; Koen van de Wetering
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

10.  Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification.

Authors:  Joshua A F Balderman; Hae-Young Lee; Christopher E Mahoney; Diane E Handy; Kevin White; Sofia Annis; Djamel Lebeche; Roger J Hajjar; Joseph Loscalzo; Jane A Leopold
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

View more
  109 in total

1.  Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise.

Authors:  Amaryllis H Van Craenenbroeck; Kristien J Ledeganck; Katrijn Van Ackeren; Angelika Jürgens; Vicky Y Hoymans; Erik Fransen; Volker Adams; Benedicte Y De Winter; Gert A Verpooten; Christiaan J Vrints; Marie M Couttenye; Emeline M Van Craenenbroeck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

2.  Decreases in plasma MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in uremic patients during hemodialysis.

Authors:  Li-Che Lu; Chung-Wei Yang; Wen-Yeh Hsieh; Wan-Hsuan Chuang; Yi-Chang Lin; Chih-Sheng Lin
Journal:  Clin Exp Nephrol       Date:  2015-12-28       Impact factor: 2.801

3.  LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.

Authors:  Wanghui Jing; Nosratola D Vaziri; Ane Nunes; Yasunori Suematsu; Ted Farzaneh; Mahyar Khazaeli; Hamid Moradi
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

4.  Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Joshua D Bundy; Xuan Cai; Julia J Scialla; Mirela A Dobre; Jing Chen; Chi-Yuan Hsu; Mary B Leonard; Alan S Go; Panduranga S Rao; James P Lash; Raymond R Townsend; Harold I Feldman; Ian H de Boer; Geoffrey A Block; Myles Wolf; Edward R Smith; Andreas Pasch; Tamara Isakova
Journal:  Am J Kidney Dis       Date:  2019-03-29       Impact factor: 8.860

5.  JAK2/STAT3/BMP-2 axis and NF-κB pathway are involved in erythropoietin-induced calcification in rat vascular smooth muscle cells.

Authors:  Jin He; Xiaoyi Zhong; Lin Zhao; Hua Gan
Journal:  Clin Exp Nephrol       Date:  2018-11-07       Impact factor: 2.801

6.  SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.

Authors:  Jakob Voelkl; Trang Td Luong; Rashad Tuffaha; Katharina Musculus; Tilman Auer; Xiaoming Lian; Christoph Daniel; Daniel Zickler; Beate Boehme; Michael Sacherer; Bernhard Metzler; Dietmar Kuhl; Maik Gollasch; Kerstin Amann; Dominik N Müller; Burkert Pieske; Florian Lang; Ioana Alesutan
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

7.  Hydroxyapatite-binding micelles for the detection of vascular calcification in atherosclerosis.

Authors:  Deborah D Chin; Jonathan Wang; Margot Mel de Fontenay; Anastasia Plotkin; Gregory A Magee; Eun Ji Chung
Journal:  J Mater Chem B       Date:  2019-09-25       Impact factor: 6.331

8.  Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.

Authors:  Jakob Voelkl; Rashad Tuffaha; Trang T D Luong; Daniel Zickler; Jaber Masyout; Martina Feger; Nicolas Verheyen; Florian Blaschke; Makoto Kuro-O; Andreas Tomaschitz; Stefan Pilz; Andreas Pasch; Kai-Uwe Eckardt; Juergen E Scherberich; Florian Lang; Burkert Pieske; Ioana Alesutan
Journal:  J Am Soc Nephrol       Date:  2018-04-13       Impact factor: 10.121

9.  Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation.

Authors:  Ken Kitamura; Hideki Fujii; Kentaro Nakai; Keiji Kono; Shunsuke Goto; Tatsuya Nishii; Atsushi Kono; Shinichi Nishi
Journal:  Heart Vessels       Date:  2017-03-21       Impact factor: 2.037

10.  Flavocoxid Ameliorates Aortic Calcification Induced by Hypervitaminosis D3 and Nicotine in Rats Via Targeting TNF-α, IL-1β, iNOS, and Osteogenic Runx2.

Authors:  Ahmed E Amer; George S G Shehatou; Hassan A El-Kashef; Manar A Nader; Ahmed R El-Sheakh
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-26       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.